These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35443946)

  • 1. Treatment persistence and exacerbations in patients with asthma initiating treatment with inhaled corticosteroids and beta-adrenergic agonists: retrospective cohort study.
    Sicras-Mainar A; Gómez Rodríguez B; Traseira-Lugilde S; Fernández-Sánchez T; Velasco Garrido JL
    BMJ Open; 2022 Apr; 12(4):e053964. PubMed ID: 35443946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting β
    Wang MT; Lai JH; Huang YL; Liou JT; Cheng SH; Lin CW; Pan HY; Hsu YJ; Tsai CL
    Chest; 2021 Oct; 160(4):1255-1270. PubMed ID: 34023320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.
    Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
    Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence and Adherence to ICS/LABA Drugs in UK Patients with Asthma: A Retrospective New-User Cohort Study.
    Parimi M; Svedsater H; Ann Q; Gokhale M; Gray CM; Hinds D; Nixon M; Boxall N
    Adv Ther; 2020 Jun; 37(6):2916-2931. PubMed ID: 32361850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication adherence in patients with asthma using once-daily versus twice-daily ICS/LABAs.
    Averell CM; Stanford RH; Laliberté F; Wu JW; Germain G; Duh MS
    J Asthma; 2021 Jan; 58(1):102-111. PubMed ID: 31607180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Persistence to treatment and resources use with inhaled fixed-dose combinations of corticosteroids and long-acting β-adrenergic agonists for the treatment of asthma: A population-based retrospective study].
    Sicras-Mainar A; Traseira-Lugilde S; Fernández-Sánchez T; Navarro-Artieda R
    Semergen; 2018 Oct; 44(7):472-484. PubMed ID: 29545018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-daily fluticasone furoate/vilanterol versus twice-daily fluticasone propionate/salmeterol in patients with asthma well controlled on ICS/LABA.
    Bernstein D; Andersen L; Forth R; Jacques L; Yates L
    J Asthma; 2018 Sep; 55(9):984-993. PubMed ID: 28961020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of COPD-related outcomes in patients initiating a once daily or twice daily ICS/LABA.
    Stanford RH; Parker ED; Reinsch TK; Buikema AR; Blauer-Peterson C
    Respir Med; 2019 Apr; 150():1-7. PubMed ID: 30961933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of once-daily fluticasone furoate/vilanterol (FF/VI) versus twice-daily inhaled corticosteroids/long-acting β
    Devillier P; Humbert M; Boye A; Zachgo W; Jacques L; Nunn C; West S; Nicholls A; Antoun Z; Spinu L; Grouin JM
    Respir Med; 2018 Aug; 141():111-120. PubMed ID: 30053956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C; Wu EQ; Ray S; Colice GL
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-daily fluticasone furoate/vilanterol versus twice daily combination therapies in asthma-mixed treatment comparisons of clinical efficacy.
    Svedsater H; Stynes G; Wex J; Frith L; Leather D; Castelnuovo E; Detry M; Berry S
    Asthma Res Pract; 2016; 2():4. PubMed ID: 27965772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years.
    Main C; Shepherd J; Anderson R; Rogers G; Thompson-Coon J; Liu Z; Hartwell D; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
    Health Technol Assess; 2008 May; 12(20):1-174, iii-iv. PubMed ID: 18485272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Safety Profile of the Fixed-Dose Combination Corticosteroid and Long-acting β
    Price DB; Carter V; Martin J; Gardener EA; Skinner D; Yang S; Hoffman M; Willis JC; Cooper AJ
    Drugs; 2020 Jan; 80(1):47-60. PubMed ID: 31749061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An innovative corticosteroid/long-acting β
    Usmani O; Roche N; Marshall J; Danagher H; Price D
    Expert Opin Drug Deliv; 2019 Dec; 16(12):1367-1380. PubMed ID: 31752560
    [No Abstract]   [Full Text] [Related]  

  • 15. Symptom control in patients with asthma using inhaled corticosteroids/long-acting β
    Averell CM; Laliberté F; Germain G; Duh MS; Lima R; Mahendran M; Slade DJ
    J Asthma; 2022 Sep; 59(9):1805-1818. PubMed ID: 34375568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of early effects of budesonide/formoterol maintenance and reliever therapy with fluticasone furoate/vilanterol for asthma patients requiring step-up from inhaled corticosteroid monotherapy.
    Hozawa S; Terada M; Haruta Y; Hozawa M
    Pulm Pharmacol Ther; 2016 Apr; 37():15-23. PubMed ID: 26850307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD.
    Ming SWY; Haughney J; Ryan D; Small I; Lavorini F; Papi A; Singh D; Halpin DMG; Hurst JR; Patel S; Ochel M; Kocks J; Carter V; Hardjojo A; Price DB
    Int J Chron Obstruct Pulmon Dis; 2020; 15():3093-3103. PubMed ID: 33273812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vilanterol and fluticasone furoate for asthma.
    Dwan K; Milan SJ; Bax L; Walters N; Powell C
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD010758. PubMed ID: 27582089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Adherence and Asthma Medication Ratio for a Once-Daily and Twice-Daily Inhaled Corticosteroid/Long-Acting β-Agonist for Asthma.
    Stanford RH; Averell C; Parker ED; Blauer-Peterson C; Reinsch TK; Buikema AR
    J Allergy Clin Immunol Pract; 2019; 7(5):1488-1496.e7. PubMed ID: 30639604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma Management.
    Singh D; Garcia G; Maneechotesuwan K; Daley-Yates P; Irusen E; Aggarwal B; Boucot I; Berend N
    Adv Ther; 2022 May; 39(5):1895-1914. PubMed ID: 35284999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.